Advertisement
Screener

EIKON THERAPEUTICS, INC. (EIKN) Scorecard

2.8 / 5 stars · 68/120 Roast Me

EIKON THERAPEUTICS, INC. (EIKN) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
1/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinEIKN / S&P
23.35% / 15.20% 		LoseEIKN / S&P
EIKN unavailable / 15.00% 		LoseEIKN / S&P
EIKN unavailable / 50.40%
2026-Q10/3 LoseEIKN / S&P
EIKN unavailable / -4.33% 		LoseEIKN / S&P
EIKN unavailable / 11.30% 		LoseEIKN / S&P
EIKN unavailable / 27.70%
2025-Q40/3 LoseEIKN / S&P
EIKN unavailable / 2.65% 		LoseEIKN / S&P
EIKN unavailable / 9.00% 		LoseEIKN / S&P
EIKN unavailable / 13.40%
2025-Q30/3 LoseEIKN / S&P
EIKN unavailable / 8.12% 		LoseEIKN / S&P
EIKN unavailable / 4.61% 		LoseEIKN / S&P
EIKN unavailable / 13.45%
2025-Q20/3 LoseEIKN / S&P
EIKN unavailable / 10.94% 		LoseEIKN / S&P
EIKN unavailable / 4.83% 		LoseEIKN / S&P
EIKN unavailable / 10.63%
2025-Q10/3 LoseEIKN / S&P
EIKN unavailable / -4.27% 		LoseEIKN / S&P
EIKN unavailable / 4.98% 		LoseEIKN / S&P
EIKN unavailable / 10.57%
2024-Q40/3 LoseEIKN / S&P
EIKN unavailable / 2.41% 		LoseEIKN / S&P
EIKN unavailable / 5.25% 		LoseEIKN / S&P
EIKN unavailable / 6.15%
2024-Q30/3 LoseEIKN / S&P
EIKN unavailable / 5.89% 		LoseEIKN / S&P
EIKN unavailable / 5.89% 		LoseEIKN / S&P
EIKN unavailable / 6.11%
2024-Q20/3 LoseEIKN / S&P
EIKN unavailable / 4.28% 		LoseEIKN / S&P
EIKN unavailable / 5.38% 		LoseEIKN / S&P
EIKN unavailable / 5.12%
2024-Q10/3 LoseEIKN / S&P
EIKN unavailable / 10.56% 		LoseEIKN / S&P
EIKN unavailable / 5.71% 		LoseEIKN / S&P
EIKN unavailable / 5.59%
2023-Q40/3 LoseEIKN / S&P
EIKN unavailable / 11.69% 		LoseEIKN / S&P
EIKN unavailable / 6.81% 		LoseEIKN / S&P
EIKN unavailable / 7.78%
2023-Q30/3 LoseEIKN / S&P
EIKN unavailable / -3.27% 		LoseEIKN / S&P
EIKN unavailable / 7.52% 		LoseEIKN / S&P
EIKN unavailable / -5.03%
2023-Q20/3 LoseEIKN / S&P
EIKN unavailable / 8.74% 		LoseEIKN / S&P
EIKN unavailable / 9.50% 		LoseEIKN / S&P
EIKN unavailable / -8.57%
2023-Q10/3 LoseEIKN / S&P
EIKN unavailable / 7.50% 		LoseEIKN / S&P
EIKN unavailable / 10.77% 		LoseEIKN / S&P
EIKN unavailable / -15.69%
2022-Q40/3 LoseEIKN / S&P
EIKN unavailable / 7.56% 		LoseEIKN / S&P
EIKN unavailable / 11.88% 		LoseEIKN / S&P
EIKN unavailable / -17.99%
2022-Q30/3 LoseEIKN / S&P
EIKN unavailable / -4.88% 		LoseEIKN / S&P
EIKN unavailable / 13.47% 		LoseEIKN / S&P
EIKN unavailable / -1.41%
2022-Q20/3 LoseEIKN / S&P
EIKN unavailable / -16.10% 		LoseEIKN / S&P
EIKN unavailable / 13.71% 		LoseEIKN / S&P
EIKN unavailable / 11.04%
2022-Q10/3 LoseEIKN / S&P
EIKN unavailable / -4.60% 		LoseEIKN / S&P
EIKN unavailable / 15.97% 		LoseEIKN / S&P
EIKN unavailable / 42.23%
2021-Q40/3 LoseEIKN / S&P
EIKN unavailable / 11.03% 		LoseEIKN / S&P
EIKN unavailable / 15.00% 		LoseEIKN / S&P
EIKN unavailable / 96.40%
2021-Q30/3 LoseEIKN / S&P
EIKN unavailable / 0.58% 		LoseEIKN / S&P
EIKN unavailable / 10.77% 		LoseEIKN / S&P
EIKN unavailable / 69.42%
2021-Q20/3 LoseEIKN / S&P
EIKN unavailable / 8.55% 		LoseEIKN / S&P
EIKN unavailable / 6.58% 		LoseEIKN / S&P
EIKN unavailable / 51.81%
2021-Q10/3 LoseEIKN / S&P
EIKN unavailable / 6.17% 		LoseEIKN / S&P
EIKN unavailable / -1.06% 		LoseEIKN / S&P
EIKN unavailable / 7.39%
2020-Q40/3 LoseEIKN / S&P
EIKN unavailable / 12.15% 		LoseEIKN / S&P
EIKN unavailable / -3.72% 		LoseEIKN / S&P
EIKN unavailable / -33.42%
2020-Q30/3 LoseEIKN / S&P
EIKN unavailable / 8.93% 		LoseEIKN / S&P
EIKN unavailable / -2.04% 		LoseEIKN / S&P
EIKN unavailable / -27.10%
2020-Q20/3 LoseEIKN / S&P
EIKN unavailable / 20.54% 		LoseEIKN / S&P
EIKN unavailable / -0.46% 		LoseEIKN / S&P
EIKN unavailable / -27.11%
2020-Q10/3 LoseEIKN / S&P
EIKN unavailable / -19.60% 		LoseEIKN / S&P
EIKN unavailable / 3.47% 		LoseEIKN / S&P
EIKN unavailable / -14.75%
2019-Q40/3 LoseEIKN / S&P
EIKN unavailable / 9.07% 		LoseEIKN / S&P
EIKN unavailable / 5.36% 		LoseEIKN / S&P
EIKN unavailable / 2.99%
2019-Q30/3 LoseEIKN / S&P
EIKN unavailable / 1.70% 		LoseEIKN / S&P
EIKN unavailable / 5.02% 		LoseEIKN / S&P
EIKN unavailable / 0.21%
2019-Q20/3 LoseEIKN / S&P
EIKN unavailable / 4.30% 		LoseEIKN / S&P
EIKN unavailable / 6.64% 		LoseEIKN / S&P
EIKN unavailable / 8.65%
2019-Q10/3 LoseEIKN / S&P
EIKN unavailable / 13.65% 		LoseEIKN / S&P
EIKN unavailable / 8.12% 		LoseEIKN / S&P
EIKN unavailable / 14.29%
2018-Q40/3 LoseEIKN / S&P
EIKN unavailable / -13.52% 		LoseEIKN / S&P
EIKN unavailable / 9.05% 		LoseEIKN / S&P
EIKN unavailable / 18.23%
2018-Q30/3 LoseEIKN / S&P
EIKN unavailable / 7.71% 		LoseEIKN / S&P
EIKN unavailable / 10.21% 		LoseEIKN / S&P
EIKN unavailable / 19.06%
2018-Q20/3 LoseEIKN / S&P
EIKN unavailable / 3.43% 		LoseEIKN / S&P
EIKN unavailable / 9.03% 		LoseEIKN / S&P
EIKN unavailable / 14.46%
2018-Q10/3 LoseEIKN / S&P
EIKN unavailable / -0.76% 		LoseEIKN / S&P
EIKN unavailable / 7.68% 		LoseEIKN / S&P
EIKN unavailable / 12.46%
2017-Q40/3 LoseEIKN / S&P
EIKN unavailable / 6.64% 		LoseEIKN / S&P
EIKN unavailable / 7.03% 		LoseEIKN / S&P
EIKN unavailable / 13.82%
2017-Q30/3 LoseEIKN / S&P
EIKN unavailable / 4.48% 		LoseEIKN / S&P
EIKN unavailable / 5.68% 		LoseEIKN / S&P
EIKN unavailable / 17.57%
2017-Q20/3 LoseEIKN / S&P
EIKN unavailable / 3.09% 		LoseEIKN / S&P
EIKN unavailable / 4.83% 		LoseEIKN / S&P
EIKN unavailable / 17.74%
2017-Q10/3 LoseEIKN / S&P
EIKN unavailable / 6.07% 		LoseEIKN / S&P
EIKN unavailable / 3.67% 		LoseEIKN / S&P
EIKN unavailable / 13.32%
2016-Q40/3 LoseEIKN / S&P
EIKN unavailable / 3.82% 		LoseEIKN / S&P
EIKN unavailable / 2.09% 		LoseEIKN / S&P
EIKN unavailable / 7.05%
2016-Q30/3 LoseEIKN / S&P
EIKN unavailable / 3.85% 		LoseEIKN / S&P
EIKN unavailable / 0.20% 		LoseEIKN / S&P
EIKN unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2026-02-05 to 2026-08-27

MetricEIKN total returnS&P 500 Total Return Index
Total return-23.20%20.78%
Annualized return-23.20%20.78%

5Y · 2026-02-05 to 2026-08-27

MetricEIKN total returnS&P 500 Total Return Index
Total return-23.20%83.14%
Annualized return-5.14%12.86%

10Y · 2026-02-05 to 2026-08-27

MetricEIKN total returnS&P 500 Total Return Index
Total return-23.20%319.30%
Annualized return-2.61%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Entera Bio Ltd. (ENTX)$0.485B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
Autolus Therapeutics plc (AUTL)$0.506B-1.52
AGENUS INC (AGEN)United States$0.383B1.41
Advertisement